Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
-
Microbot Medical® to Participate at the 38th Annual Roth Conference
-
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
-
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
-
Microbot Medical® to Leverage Current Users Experience of LIBERTY® at Key Oncology Conference to Support Commercial Adoption.
-
Publicly traded firm accelerates growth in the $39B nightlife industry, expanding modern hospitality brands nationwide.
-
New interviews reveal expansion strategy in adult hospitality, with acquisitions and board changes ahead.
-
Financial review begins as part of expansion into adult hospitality, positioning a public company for growth, acquisitions, and investor value.
-
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System.
-
FDA 510(k) Submission Follows the Successful Completion of the Pivotal Human Clinical Trial FDA 510(k) Clearance Anticipated During the Second Quarter of 2025 Company Preparing to Commence...